It is recognized that exacerbations of multiple sclerosis (MS) may be related to a variety of stressful situations more frequently than could be accounted for by coincidence (British Medical Journal, 1967) . There is evidence that ACTH therapy benefits acute relapses of the disease and in recent years an intriguing relationship between demyelination and adrenal disease has been recognized (Eadie, 1966 (1952) and Alexander, Cass, Enders, and Sarai (1966) suggested that adrenocortical function is normal in multiple sclerosis. In a preliminary investigation Teasdale, Smith, Wilkinson, Latner, and Miller (1967) also concluded that adrenocortical responses were normal in multiple sclerosis but found that the rise in plasma cortisol seen with insulin-induced hypoglycaemia was significantly less than that of healthy controls. On the basis of these findings they indicated the possibility of an impaired stress response, mediated at the hypothalamic level, in multiple sclerosis. The present investigation extends these observations by assessing the entire cerebropituitary-adrenocortical axis in a group of MS patients, making comparisons with other patients in the neurological ward and a group of healthy subjects.
SUBJECTS AND METHODS
'Thirty patients with multiple sclerosis were studied. There were 12 males and 18 females. Sixteen patients had developed fresh symptoms and signs in the fortnight before admission and are referred to as the acute cases. In the remainder (chronic group) the disease had been clinically quiescent for at least a year. All patients were ambulant before hospitalization and none had pressure sores or intercurrent systemic disease. None had received steroid therapy in the year before admission or a prolonged course of such treatment at any time. For comparison, 20 patients of similar age, sex, and duration of hospital stay, but with a variety of neurological diseases other than demyelinating disease, were investigated with their knowledge and consent. Of these patients, five had been investigated with negative results for a variety of symptoms of which headache was the most prominent. Definitive diagnoses were cerebral tumour (2), syringomyelia (3), prolapsed intervertebral disc (3), migraine (2), familial ataxia (1), chorea (1), neurofibromatosis (1), and radiation myelopathy (1). One young woman had multiple cranial nerve palsies for which no cause was apparent after one year's follow-up. In addition the response of 12 healthy subjects to lysine8-vasopressin (LVP) was measured. For all tests, subjects fasted overnight and remained at rest during the procedure. At least 24 hours elapsed between procedures, which commenced at 9.30 a.m. and were carried out in random sequence. Blood samples were collected by repeated venepunctures into heparinized tubes and plasma cortisols were determined using the method of Stewart, Albert-Recht, and Osman (1961) by one of us (D.B.C.) who was unaware of the source of individual blood samples.
Adrenocortical function was measured by the method of Wood, Frankland, James, and Landon (1965) . Plasma cortisols were determined immediately before and 30 minutes after the intramuscular injections of 0-25 mg of a synthetic polypeptide, P 1-24ACTH (Synacthen, Ciba), dissolved in 1-0 ml. physiological saline. The plasma cortisol response to LVP was measured in the manner described by Gwinup (1965) . Blood was drawn for plasma cortisol determinations immediately before and 30, 60, 90, and 120 minutes after an intramuscular injection of 10 pressor units of synthetic LVP (Sandoz, batch no. 67001).
Plasma cortisol responses to insulin induced hypoglycaemia were determined by the technique of Greenwood, Landon, and Stamp (1966) . Cortisol estimations were made immediately before and 30, 60. 90 and 120 minutes after the intravenous administration of 0-15 units insulin per kg body weight.
RESULTS
No untoward reactions were encountered throughout this trial, and no patient required dextrose during induced hypoglycaemia. RESPONSE TO SYNACTHEN There was no significant difference in the mean rise in plasma cortisol seen in acutely relapsed MS patients, chronic MS cases, or 414 neurological controls (Table I) . Basal cortisol values were lower in the patients with chronic multiple sclerosis than the other two groups, but the means did not differ significantly.
RESPONSE TO HYPOGLYCAEMIA Fasting blood sugars did not differ significantly between the three patient groups (Fig. 1) . The mean fall in blood sugar was also similar but blood sugars returned towards the basal level somewhat more slowly in the chronic MS patients. In all three groups there was a significant rise in plasma cortisol 60 minutes after injection of insulin (Fig. 2, Table II) . A smaller increiment was seen in acutely relapsed MS patients than in chronic MS cases (P < 0 02) but in neither of these groups did it differ significantly from that in patients with other neurological diseases. Basal plasma cortisol readings for the acute MS patients were higher than those for the neurological controls and the means differed significantly (P < 0 05). Plasma cortisol levels tended to fall back to their initial levels more slowly in both acute and chronic MS patients.
RESPONSE TO VASOPRESSIN It has been noted that subjects may fail to respond to LVP for no apparent reason (Wynn, 1967) . In this series a non-reactor was arbitrarily defined as an individual showing a rise in plasma cortisol of less than 5 ,g/ml. (Czarny, James, Landon, and Greenwood, 1968) . There were two non-reactors among the 14 MS patients studied, none in the 14 chronic cases, four out of 20 neurological controls, and two among the 12 healthy subjects. All patients who did not respond to LVP showed good responses to insulin hypoglycaemia. Results from non-reactors were not included in the subsequent analysis.
The incremental responses to LVP were very similar in the four groups of subjects (Table 111) . However in both groups of patients with multiple sclerosis the response fell away more slowly, resulting in significantly higher plasma cortisol levels at 60 minutes (acute and chronic MS) and 90 minutes (acute MS) than in neurological control cases. The plasma cortisol levels in MS patients were significantly greater than those of healthy control subjects at each sampling time.
DISCUSSION
The endocrine responses of patients with multiple sclerosis did not differ greatly from those given by patients with other neurological disorders. During hypoglycaemic stress MS patients gave mean plasma cortisol values in close agreement with those obtained by Teasdale et al. (1967) . These workers suggested that the response by their MS subjects was impaired, as the mean increment in plasma cortisol was significantly less than that encountered in a previous series of healthy controls. They therefore suggested that a degree of hypothalamic impairment may be present. Yet in this study there was no significant difference between the incremental responses of MS 5/9 16-5 ± 1-6 15-1 ± 1-2 22-4 ± 1-0 21-4 ± 1-3 20-2 + 1-4
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